PECAM1 and neoplasm: To evaluate whether D2R agonist treatment promotes apoptosis of tumour-associated endothelial cells, we performed ex vivo co-immunofluorescence staining with TUNEL and anti-CD31 antibodies using SCLC tissue specimens derived from mice harbouring the chemotherapy-resistant MSK-LX40R PDX.